<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>33</volume>
<number>156</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>A Comprehensive Study of Guanylate-Binding Protein Family Members as Prognostic marker in Breast Cancer</title>
	<subject_fa>Medical Biology</subject_fa>
	<subject>Medical Biology</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Background:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt; Breast cancer (BrCa) is the most prevalent tumor among women globally, aside from nonmelanoma skin malignancies. Unfortunately, many BrCa patients exhibit a poor response to immune checkpoint inhibitors (ICIs) because of a deficiency of infiltrating immune cells. Earlier research has shown that guanylate-binding protein 1 (GBP1) can modify the inhibitory properties of inflammatory cytokines on endothelial cell proliferation, immigration, and invasion.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Objective:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Since the fundamental functions of the GBP family in the cancer-immune cycle is uncertain, according to recent findings, the function of GBPs in BrCa was studied. However, the underlying function of the GBP family in the cancer-immunity cycle is uncertain. We decided to study GBPs&amp;rsquo; role in BrCa.&lt;span style=&quot;color:#0e101a&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Methods:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt; We applied GEPIA, UALCAN, cBioPortal, GeneMANIA, Kaplan-Meier plotter, Human Protein Atlas, STRING, and TIMER in our analysis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Results:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt; Our results confirmed a strong relation between the expression of GBP1/GBP2/GBP3/GBP4/GBP5/GBP6/GBP7 and the infiltration of all immune cells. Specifically, high GBP1/4/5 expression was strongly linked with increased infiltration of dendritic cells, B cells, CD4+ T cells, CD8+ T cells, and neutrophils in BrCa, whereas GBP2/3/6/7 expression showed a weaker positive correlation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;color:#0e101a&quot;&gt; These results suggest a therapeutic assessment for the GBP family in combination with ICIs for treating BrCa.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Prognostic, Guanylate-Binding Proteins, Immune Infiltrates, Breast Cancer</keyword>
	<start_page>18</start_page>
	<end_page>27</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-5411-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Samaneh</first_name>
	<middle_name></middle_name>
	<last_name>Biglari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>samaneh.biglari92@gmail.com</email>
	<code>5200319475328460082805</code>
	<orcid>5200319475328460082805</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Haleh</first_name>
	<middle_name></middle_name>
	<last_name>Siami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>haleh.siami@yahoo.com</email>
	<code>5200319475328460082806</code>
	<orcid>5200319475328460082806</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Medicine, Islamic Azad university of Medical Science, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Ghahremani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghahramaniz@zums.ac.ir</email>
	<code>5200319475328460082807</code>
	<orcid>5200319475328460082807</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Radiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Negin</first_name>
	<middle_name></middle_name>
	<last_name>Parsamanesh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>neginparsa.684@gmail.com</email>
	<code>5200319475328460082808</code>
	<orcid>5200319475328460082808</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
